WallStSmart
ACAD

ACADIA Pharmaceuticals Inc

NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY

$22.20
-2.07% today

Updated 2026-04-29

Market cap
$3.80B
P/E ratio
9.65
P/S ratio
3.55x
EPS (TTM)
$2.30
Dividend yield
52W range
$14 – $28
Volume
1.9M

ACADIA Pharmaceuticals Inc (ACAD) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$62.51M$89.54M$134.58M$64.68M$49.68M$38.39M$32.11M$108.59M$189.12M$325.46M$221.90M$561.15M$384.51M$540.20M$783.18M$782.62M$700.12M$587.81M$748.96M$1.19B
Cash & equivalents
Current assets$60.12M$85.78M$131.25M$62.38M$48.47M$37.85M$31.95M$108.55M$188.36M$324.62M$218.99M$547.90M$373.48M$526.11M$760.25M$717.62M$617.82M$507.94M$616.13M$938.32M
Total liabilities$23.13M$22.39M$20.65M$11.69M$37.57M$8.71M$8.75M$23.61M$6.99M$15.97M$22.13M$42.74M$49.22M$61.12M$84.05M$155.61M$159.23M$187.40M$317.20M$454.96M
Current liabilities$21.70M$20.53M$19.29M$11.05M$14.71M$5.96M$6.17M$5.95M$6.98M$15.83M$21.90M$42.59M$49.03M$59.56M$74.83M$105.97M$96.07M$125.63M$254.25M$394.87M
Long-term debt$892000.00$1.38M$1.16M$430000.00$98000.00$32000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Shareholder equity
Retained earnings$-128.42M$-173.47M$-229.86M$-294.10M$-339.25M$-324.11M$-346.87M$-367.72M$-405.67M$-498.14M$-662.59M$-933.98M$-1.22B$-1.47B$-1.70B$-1.99B$-2.15B$-2.37B$-2.43B$-2.20B
Accounts receivable$964000.00$1.64M$7.14M$18.43M$27.79M$37.87M$50.28M$65.34M$63.08M$102.35M$104.69M
Inventory$0.00$0.00$0.00$0.00$0.00$4.17M$5.25M$4.07M$6.34M$9.68M$7.88M$6.64M$35.82M$21.95M
Goodwill$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.00